Rhonda Hellums
Vermögen: 2 700 $ am 30.11.2025
Vermögen: 2 700 $ am 30.11.2025
Rhonda L.
Hellums is currently Principal at Summit Springs LLC since 2010 and CFO, Secretary & Executive Director at Silence Therapeutics Plc starting in 2025.
Former positions include Chief Financial Officer at Deer Oaks Mental Health Associates from 2019 to 2021, Chief Financial Officer & Treasurer at Aratana Therapeutics, Inc. in 2019, Director-Global Finance at Kinetic Concepts, Inc. from 2010 to 2014, Vice President-Finance at Enzon Pharmaceuticals, Inc. from 2006 to 2010, Director-Finance, Alliance & Strategic at Genzyme Corp.
from 2001 to 2005, Controller at E.G.&G., Inc. from 1999 to 2001.
Education includes undergraduate and MBA degrees from the University of Texas at San Antonio.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 1’500 ( 0% ) | 2 700 $ | 30.11.2025 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Finanzdirektor/CFO | 21.02.2022 |
Summit Springs LLC | Corporate Officer/Principal | 01.08.2010 |
| Unternehmen | Position | Ende |
|---|---|---|
Deer Oaks Mental Health Associates
Deer Oaks Mental Health Associates Medical/Nursing ServicesHealth Services Provides behavioral health, psychological and psychiatric services | Finanzdirektor/CFO | 01.01.2021 |
| ARATANA THERAPEUTICS INC | Finanzdirektor/CFO | 01.09.2019 |
Kinetic Concepts, Inc.
Kinetic Concepts, Inc. Medical SpecialtiesHealth Technology Develops advanced wound care solutions and therapies | Corporate Officer/Principal | 01.01.2014 |
Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Corporate Officer/Principal | 01.01.2010 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Finanzdirektor/CFO | 01.01.2005 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Health Technology |
Kinetic Concepts, Inc.
Kinetic Concepts, Inc. Medical SpecialtiesHealth Technology Develops advanced wound care solutions and therapies | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Aratana Therapeutics, Inc.
Aratana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercialization therapeutics for dogs & cats | Health Technology |
Silence Therapeutics Plc
Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
E.G.&G., Inc.
E.G.&G., Inc. Miscellaneous Commercial ServicesCommercial Services Provides landscape, planning and engineering services | Commercial Services |
University of Texas at San Antonio
University of Texas at San Antonio Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Summit Springs LLC | |
Deer Oaks Mental Health Associates
Deer Oaks Mental Health Associates Medical/Nursing ServicesHealth Services Provides behavioral health, psychological and psychiatric services | Health Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen